These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of Kawasaki A; Sada KE; Kusumawati PA; Hirano F; Kobayashi S; Nagasaka K; Sugihara T; Ono N; Fujimoto T; Kusaoi M; Tamura N; Kusanagi Y; Itoh K; Sumida T; Yamagata K; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N Front Immunol; 2023; 14():1119064. PubMed ID: 36969218 [TBL] [Abstract][Full Text] [Related]
5. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA; Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324 [TBL] [Abstract][Full Text] [Related]
6. The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population. Lundtoft C; Knight A; Meadows JRS; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Eriksson P; Söderkvist P; Ronnblom L; Omdal R; Jonsson R; Lindblad-Toh K; Dahlqvist J RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580345 [TBL] [Abstract][Full Text] [Related]
7. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis. Li W; Huang H; Cai M; Yuan T; Sheng Y Front Immunol; 2021; 12():624848. PubMed ID: 33841406 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U; Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. Kim SM; Choi SY; Kim SY; Kim J Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433 [TBL] [Abstract][Full Text] [Related]
11. Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis. Wang HY; Cui Z; Pei ZY; Fang SB; Chen SF; Zhu L; Chen M; Chen N; Zhao MH Kidney Int; 2019 Oct; 96(4):1010-1019. PubMed ID: 31471160 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690 [TBL] [Abstract][Full Text] [Related]
13. PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules. Gregersen JW; Erikstrup C; Ivarsen P; Glerup R; Krarup E; Keller KK; Hansen IT; Møller BK Rheumatology (Oxford); 2019 Nov; 58(11):1942-1949. PubMed ID: 30938436 [TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. Chang DY; Li ZY; Chen M; Zhao MH Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327 [TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study. Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW Clin Rheumatol; 2024 Jan; 43(1):367-376. PubMed ID: 37530864 [TBL] [Abstract][Full Text] [Related]
16. HLA sequencing identifies novel associations and suggests clinical relevance of DPB1*04:01 in ANCA-associated Granulomatosis with polyangiitis. Senapati S; Singh H; Bk T; Verma N; Kumar U Gene; 2024 Feb; 896():148024. PubMed ID: 38040271 [TBL] [Abstract][Full Text] [Related]
17. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. Carr EJ; Niederer HA; Williams J; Harper L; Watts RA; Lyons PA; Smith KG BMC Med Genet; 2009 Dec; 10():121. PubMed ID: 19951419 [TBL] [Abstract][Full Text] [Related]
18. Associations of CTLA4 +49 A/G Dimorphism and HLA-DRB1*/DQB1* Alleles With Type 1 Diabetes from South India. Padma-Malini R; Rathika C; Ramgopal S; Murali V; Dharmarajan P; Pushkala S; Balakrishnan K Biochem Genet; 2018 Oct; 56(5):489-505. PubMed ID: 29603038 [TBL] [Abstract][Full Text] [Related]
19. HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study. Hilhorst M; Arndt F; Joseph Kemna M; Wieczorek S; Donner Y; Wilde B; Thomas Epplen J; van Paassen P; Cohen Tervaert JW Arthritis Rheumatol; 2016 Jul; 68(7):1721-30. PubMed ID: 26866715 [TBL] [Abstract][Full Text] [Related]
20. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]